Annette Feigenbaum

1.1k total citations
17 papers, 670 citations indexed

About

Annette Feigenbaum is a scholar working on Molecular Biology, Clinical Biochemistry and Cell Biology. According to data from OpenAlex, Annette Feigenbaum has authored 17 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Clinical Biochemistry and 3 papers in Cell Biology. Recurrent topics in Annette Feigenbaum's work include Metabolism and Genetic Disorders (9 papers), Mitochondrial Function and Pathology (5 papers) and ATP Synthase and ATPases Research (2 papers). Annette Feigenbaum is often cited by papers focused on Metabolism and Genetic Disorders (9 papers), Mitochondrial Function and Pathology (5 papers) and ATP Synthase and ATPases Research (2 papers). Annette Feigenbaum collaborates with scholars based in Canada, United States and United Kingdom. Annette Feigenbaum's co-authors include Jean L. Johnson, Robert M. Garrett, Tyler N. Graf, K.V. Rajagopalan, Frank Rutsch, Hans-Gerd Kehl, Mary MacDougall, Joe T.R. Clarke, Brian H. Robinson and Gillian Rice and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The American Journal of Human Genetics and The Journal of Pediatrics.

In The Last Decade

Annette Feigenbaum

17 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Feigenbaum Canada 12 372 223 151 110 82 17 670
Lee‐Jun Wong United States 17 525 1.4× 344 1.5× 25 0.2× 73 0.7× 70 0.9× 28 762
Yanling Yang China 17 576 1.5× 373 1.7× 24 0.2× 125 1.1× 48 0.6× 56 856
M. O. Rolland France 16 431 1.2× 344 1.5× 60 0.4× 101 0.9× 164 2.0× 33 787
Claude Préhu France 17 228 0.6× 34 0.2× 30 0.2× 34 0.3× 37 0.5× 71 1.0k
Müge Güçsavaş‐Çalıkoğlu United States 7 232 0.6× 143 0.6× 41 0.3× 277 2.5× 70 0.9× 10 1.1k
Sui-Fan Tong China 16 491 1.3× 47 0.2× 7 0.0× 105 1.0× 25 0.3× 37 812
L L Shelly United States 12 397 1.1× 55 0.2× 47 0.3× 567 5.2× 134 1.6× 13 985
M. Hunter Lanier United States 11 318 0.9× 37 0.2× 58 0.4× 41 0.4× 32 0.4× 20 704
Thomas Plitz United States 10 197 0.5× 12 0.1× 485 3.2× 81 0.7× 14 0.2× 12 969
Kevin Larimore United States 8 218 0.6× 229 1.0× 12 0.1× 69 0.6× 28 0.3× 16 452

Countries citing papers authored by Annette Feigenbaum

Since Specialization
Citations

This map shows the geographic impact of Annette Feigenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Feigenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Feigenbaum more than expected).

Fields of papers citing papers by Annette Feigenbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Feigenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Feigenbaum. The network helps show where Annette Feigenbaum may publish in the future.

Co-authorship network of co-authors of Annette Feigenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Feigenbaum. A scholar is included among the top collaborators of Annette Feigenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Feigenbaum. Annette Feigenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Feigenbaum, Annette, et al.. (2022). Considerations for prenatal and postpartum management of a female patient with ornithine transcarbamylase deficiency. Molecular Genetics and Metabolism Reports. 33(Suppl 1). 100894–100894. 2 indexed citations
2.
Rutsch, Frank, Mary MacDougall, Changming Lu, et al.. (2015). A Specific IFIH1 Gain-of-Function Mutation Causes Singleton-Merten Syndrome. The American Journal of Human Genetics. 96(2). 275–282. 156 indexed citations
3.
Feigenbaum, Annette, Christine Müller, Johannes Kleinheinz, et al.. (2013). Singleton–Merten syndrome: An autosomal dominant disorder with variable expression. American Journal of Medical Genetics Part A. 161(2). 360–370. 51 indexed citations
4.
Potter, Beth K., Pranesh Chakraborty, Jonathan B. Kronick, et al.. (2012). Achieving the “triple aim” for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework. Genetics in Medicine. 15(6). 415–422. 21 indexed citations
5.
Arnold, Georgianne L., Johan Van Hove, Debra Freedenberg, et al.. (2009). A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Molecular Genetics and Metabolism. 96(3). 85–90. 112 indexed citations
6.
Dimmock, David, Pamela Trapane, Annette Feigenbaum, et al.. (2009). Novel human pathological mutations. Gene symbol: ASS1. Disease: Citrullinaemia.. PubMed. 126(2). 341–341. 2 indexed citations
7.
Cameron, Jessie M., Valeriy Levandovskiy, Julian Raiman, et al.. (2006). Novel mutations in dihydrolipoamide dehydrogenase deficiency in two cousins with borderline‐normal PDH complex activity. American Journal of Medical Genetics Part A. 140A(14). 1542–1552. 46 indexed citations
8.
Somani, Sohel, Małgorzata J.M. Nowaczyk, Annette Feigenbaum, et al.. (2006). The Ocular Manifestations of Jacobsen Syndrome: A Report of Four Cases and a Review of the Literature. Ophthalmic Genetics. 27(1). 1–7. 5 indexed citations
9.
Feigenbaum, Annette, Renkui Bai, Emily S Doherty, et al.. (2006). Novel mitochondrial DNA mutations associated with myopathy, cardiomyopathy, renal failure, and deafness. American Journal of Medical Genetics Part A. 140A(20). 2216–2222. 20 indexed citations
10.
Blasér, Susan, et al.. (2006). Atypical phenotype in a boy with a maple syrup urine disease. Journal of Inherited Metabolic Disease. 29(1). 195–200. 5 indexed citations
11.
Blasér, Susan & Annette Feigenbaum. (2004). A neuroimaging approach to inborn errors of metabolism. Neuroimaging Clinics of North America. 14(2). 307–329. 17 indexed citations
12.
Stormon, Michael, et al.. (2004). A Six-month-old infant with liver steatosis. The Journal of Pediatrics. 144(2). 258–263. 12 indexed citations
13.
Feigenbaum, Annette, Robert J. Moore, Joe T.R. Clarke, et al.. (2003). Canavan disease: Carrier‐frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay. American Journal of Medical Genetics Part A. 124A(2). 142–147. 41 indexed citations
14.
Carbone, Mary Anna, N. MacKay, Mingfu Ling, et al.. (1998). Amerindian Pyruvate Carboxylase Deficiency Is Associated with Two Distinct Missense Mutations. The American Journal of Human Genetics. 62(6). 1312–1319. 38 indexed citations
15.
Garrett, Robert M., Jean L. Johnson, Tyler N. Graf, Annette Feigenbaum, & K.V. Rajagopalan. (1998). Human sulfite oxidase R160Q: Identification of the mutation in a sulfite oxidase-deficient patient and expression and characterization of the mutant enzyme. Proceedings of the National Academy of Sciences. 95(11). 6394–6398. 110 indexed citations
16.
Feigenbaum, Annette, et al.. (1996). The expanding clinical phenotype of the tRNALeu(UUR) A→G mutation at np 3243 of mitochondrial DNA: Diabetic embryopathy associated with mitochondrial cytopathy. American Journal of Medical Genetics. 62(4). 404–409. 21 indexed citations
17.
Mahuran, Don J., Barbara L. Triggs‐Raine, Annette Feigenbaum, & Roy A. Gravel. (1990). The molecular basis of Tay-Sachs disease: Mutation identification and diagnosis. Clinical Biochemistry. 23(5). 409–415. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lee‐Jun Wong Breakdown of academic impact, for papers by Yanling Yang Breakdown of academic impact, for papers by M. O. Rolland Breakdown of academic impact, for papers by Claude Préhu Breakdown of academic impact, for papers by Müge Güçsavaş‐Çalıkoğlu Breakdown of academic impact, for papers by Sui-Fan Tong Breakdown of academic impact, for papers by L L Shelly Breakdown of academic impact, for papers by M. Hunter Lanier Breakdown of academic impact, for papers by Thomas Plitz Breakdown of academic impact, for papers by Kevin Larimore
Rankless by CCL
2026